Substituted isoxazole amide compounds as inhibitors of stearoyl-CoA desaturase 1 (SCD1)
US9296711B2 · kind B2 · utility
7Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2013 |
| Grant date | Mar 29, 2016 |
| Priority date | — |
| Expiry date | Dec 2, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention is concerned with a compound of formula (I) and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and using the compound of formula (I) as well as pharmaceutical compositions containing such compounds. The compound of formula (I) are SCD1 inhibitors and may be useful in treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.